Tigecyclin represents an important contribution for treatment of difficult-to-treat infections caused by polymicrobial or resistant flora. Its characteristics destinate it for use beyond the registered indications. Authors submit two case reports documenting its promising effect in patients with complicated pulmonary infection in whom standard treatment was not successful.